ConductScience.org, home

Trial · NCT00380250

Registered outcomes29

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryOverall Responder Rate12 weeks
Monthly responder: \>=Moderately relieved symptoms 4 weeks/month or Significantly relieved \>= 2 weeks/month IF: Rescue med use did not increase during the month; AND did not discontinue during the month for lack of efficacy; AND no Moderately worse or Significantly worse response in month. Overall responder: responder for at least 2/3 months
SecondaryMonth 1 Spontaneous Bowel Movement (SBM) Frequency Rates Change From BaselineChange from baseline for month 1SBMs are any bowel movement not associated with rescue medication use.
SecondaryMonth 1 Stool Consistency Change From BaselineChange from baseline for month 10 = Very loose (watery), 1 = Loose, 2 = Normal, 3 = Hard, 4 = Very hard (little balls)
SecondaryMonth 1 Bowel Straining Change From BaselineChange from baseline for month 10 = Absent,1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 1 Constipation Severity Change From BaselineChange from baseline at 28 days0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 1 Symptom ReliefChange from baseline for month 1Significantly worse = -3; Moderately worse = -2; A little bit worse = -1; Unchanged = 0; A little bit relieved=1; Moderately relieved=2; Significantly relieved = 3
SecondaryQuality of Life Change From BaselineChange from baseline at 12 weeks
Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire included 34 questions with 5 possible responses yielding the following sub-categories: dysphoria, interference with activity, body image, health worry, food avoidance, social reaction, sexual, and relationship Results range from 34 (low) to 100 (high); meaningful clinical improvement=14 point increase
SecondaryMonth 2 Responder Ratemonth 2 (28 days)
Monthly responder: \>=Moderately relieved symptoms 4 weeks/month or Significantly relieved \>= 2 weeks/month IF: Rescue med use did not increase during the month; AND did not discontinue during the month for lack of efficacy; AND no Moderately worse or Significantly worse response in month.
SecondaryMonth 3 Responder Ratemonth 3 (28 days)
Symptoms \>= Moderately relieved for 4 weeks/month or Significantly relieved for \>=2 weeks/month AND: 1. Rescue medication use does not increase during the month as compared to baseline; 2. No discontinuation during the month due to lack of efficacy;AND 3. No ratings during the month of Moderately worse or Significantly worse.
SecondaryMonth 1 Responder Ratemonth 1 (28 days)
Symptoms \>= Moderately relieved for 4 weeks/month or Significantly relieved for \>=2 weeks/month AND: 1. Rescue medication use does not increase during the month as compared to baseline; 2. No discontinuation during the month due to lack of efficacy;AND 3. No ratings during the month of Moderately worse or Significantly worse.
SecondaryMonth 2 Abdominal Bloating Change From BaselineChange from baseline for month 20 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 3 Abdominal Bloating Change From BaselineChange from baseline for month 30 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 2 Spontaneous Bowel Movement Frequency Rates Change From BaselineChange from baseline for month 2Any bowel movement not associated with rescue medication use
SecondaryMonth 3 Spontaneous Bowel Movement Frequency Rates Change From BaselineChange from baseline for month 3Any bowel movement not associated with rescue medication use
SecondaryMonth 2 Stool Consistency Change From BaselineChange from baseline for month 20 = Very loose (watery), 1 = Loose, 2 = Normal, 3 = Hard, 4 = Very hard (little balls)
SecondaryMonth 3 Stool Consistency Change From BaselineChange from baseline for month 30 = Very loose (watery), 1 = Loose, 2 = Normal, 3 = Hard, 4 = Very hard (little balls)
SecondaryMonth 2 Bowel Straining Change From BaselineChange from baseline for month 20 = Absent,1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 3 Bowel Straining Change From BaselineChange from baseline for month 30 = Absent,1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 2 Constipation Severity Change From BaselineChange from baseline for month 20 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe
SecondaryMonth 3 Constipation Severity Change From BaselineChange from baseline for month 30 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00380250/registered